ロード中...
Immunotherapy Is Changing First-Line Treatment of Metastatic Renal-Cell Carcinoma
The incidence of renal-cell carcinoma has been increasing each year, with nearly one third of new cases diagnosed at advanced or metastatic stage. The advent of targeted therapies for metastatic renal-cell carcinoma (mRCC) has underscored the need to subtype tumors according to tumor-immune expressi...
保存先:
| 出版年: | Clin Genitourin Cancer |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7004481/ https://ncbi.nlm.nih.gov/pubmed/30858035 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2019.01.017 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|